ReShape awarded Grant to further develop Diabetes Bloc-Stim Neuromodulation deviceReShape Lifesciences has been awarded a US$300,000 Small Business Innovation Research (SBIR) grant for the development of ReShape’s...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes10 hours ago